Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Anti-proliferative Effects of Bee Venom through Induction of Bax and Cdk Inhibitor p21WAF1/CIP1 in Human Lung Carcinoma Cells

Bax 및 Cdk inhibitor p21WAF1/CIP1 발현 증가에 의한 bee venom의 A549 인체폐암세포 성장억제

  • Choi, Yung-Hyun (Department of Biochemistry and Biomedical Research Center of Oriental Medicine, Dongeui University College of Oriental Medicine)
  • 최영현 (동의대학교 한의과대학 생화학교실 및 한방바이오연구센타)
  • Published : 2005.02.25
Download PDF
⟨ Previous Next ⟩

Abstract

To investigate the possible molecular mechanism (s) of bee venom as a candidate of anti-cancer drug, we examined the effects of the compound on the growth of human lung carcinoma cell line A549. Bee venom treatment declined the cell growth and viability of A549 cells in a concentration-dependent manner, which was associated with induction of apoptotic cell death. Bee venom down-regulated the levels of anti-apoptotic genes such as Bcl-2 and Bcl-XS/L, however, the levels of Bax, a pro-apoptotic gene, were up-regulated. Bee venom treatment induced not only tumor suppressor p53 but also cyclin-dependent kinase inhibitor p21WAF1/CIP1 expression in a dose-dependent manner. Furthermore, bee venom treatment induced the down-regulation of telomerase reverse transcriptase mRNA and telomeric repeat binding factor expression of A549 cells, however, the levels of telomerase-associated protein-1 and c-myc were not affected. Taken together, these findings suggest that bee venom-induced inhibition of human lung cancer cell growth is associated with the induction of apoptotic cell death via regulation of several major growth regulatory gene products, and bee venom may have therapeutic potential in human lung cancer.

Keywords

References

  1. Arends, M.J., Morris, R.G., Wyllie, A.H., Apoptosis. The role of the endonuclease. Am. J. Pathol. 136, 593-608, 1990.
  2. Evans, V.G., Multiple pathways to apoptosis. Cell Biol. Int. 17, 461-476, 1993.
  3. Shi, L., Nishioka, W.K., Th'ng, J., Bradbury, E.M., Litchfield, D.W., Greenberg, A.H., Premature p34cdc2 activation required for apoptosis. Science 263, 1143-1145, 1994.
  4. Nagata, S., Apoptosis by death factor. Cell 88, 355-365, 1997.
  5. Chiarugi, V., Magnelli, L., Basi, G., Apoptosis and the cell cycle. Cell. Mol. Biol. Res. 40, 603-612, 1994.
  6. 김문호. 봉독요법과 봉침요법. 서울: 한국교육기획, 1992, 95-103.
  7. 이재동, 봉독요법-임상활용방법을 중심으로, 대한한의학회지, 21, 3-8, 2000.
  8. Kwon, K.R., Hoh, H.K., Kim, C.H., The study of the introduction of bee venom acupuncture, biochemistry and pharmachology have been obtained the following results. J. Kor. Acupuncture Moxibustion Soc. 11, 159-171, 1994.
  9. Habermann, E., Chemistry, pharmacology and toxicology of bee, was p and hornet venoms. In Venomous Animals and their Venoms. Academic Press. 1971:3-61.
  10. Assem, E.S., Atkinson, G., Histamine release by MCDP (401), a peptide from the venom of the honey bee. Bri. Pharmacol. 48, 337-338, 1973.
  11. Spoerri, P.E., Apamin from bee venom. Neurobiology 3, 207-214, 1973.
  12. Vento, R., D'Alessandro, N., Giuliano, M., Lauricella, M., Carabillo, M., Tesoriere, G., Induction of apoptosis by arachidonic acid in human retinoblastoma Y79 cells: involvement of oxidative stress. Exp. Eye Res. 70, 503-517, 2000.
  13. Lee, J.H., Jin, J.D., Lee, S.W., Han, S.W., Kim, S.T., Shin, J.S., The effect of bee venom and melittin herbal acupuncture solution to apoptosis in NG pretreated neuroblastoma cell line. J. Kor. Acupuncture Moxibustion Soc. 19, 189-202, 2000.
  14. Kwon, D.H., Lee, J.D., Choi, D.Y., The study of anti-cancer effects of Bee venom for aqua-acupuncture. J. Kor. Acupuncture Moxibustion Soc. 18, 129-145, 2001.
  15. Park, C.Y., Nam, S.S., Kim, C.H., Lee, J.D., Kang, S.K, Lee, Y.H, Ahn, B.C., Molecular biological study of anti-cancer effects of bee venom on human melanoma cell. J. Kor. Acupuncture Moxibustion Soc. 17, 169-186, 2000.
  16. Martikainen, P., Nyman, K., Nevalainen, T.J., Toxic effects of human pancreatic and snake and bee venom phospholipases A2 on MCF-7 cells in culture. Toxicon 31, 835-843, 1993.
  17. Orsolic, N., Sver, L., Verstovsek, S., Terzic, S., Basic, I., Inhibition of mammary carcinoma cell proliferation in vitro and tumor growth in vivo by bee venom, Toxicon 41, 861-870, 2003.
  18. Yeo, S.W., Seo, J.C., Choi, Y.H., Jang, K.J., Induction of the growth inhibition and apoptosis by bee venom in human breast carcinoma MCF-7 cells. J. Kor. Acupuncture Moxibustion Soc. 20, 45-62, 2003.
  19. Jang, M.H., Shin, M.C., Lim, S., Han, S.M., Park, H.J., Shin, L, Lee, J.S., Kim, K.A., Kim, E.H., Kim, C.J., Bee venom induces apoptosis and inhibits expression of cyclooxygenase-2 mRNA in human lung cancer cell line NCI-H1299. J. Pharmacol., 91, 95-104, 2003.
  20. Ahn, C.B., Im, C.W., Youn, H.M., Park, S.J., Choi, Y.H., Melittin-induced apoptosis is associated with inhibition of COX-2 and hTERT expression in human lung carcinoma A549 cells. J. Kor. Acupuncture Moxibustion Soc. 20, 93-106, 2003.
  21. Ahn, C.B., Im, C.W., Kim, C.H., Youn, H.M., Jang, K.J., Song, C.H., Choi, Y.H., Apoptotic cell Death by melittin through induction of Bax and activation of caspase proteases in human lung carcinoma cells. J. Kor. Acupuncture Moxibustion Soc. 21, 41-55, 2004.
  22. Hwang, D.Y., Kim, H.H., Kim, C.J., Kim, E.H., Bee venom induces apoptosis and inhibits COX-2 in human osteosarcoma cell line MG-63. J. Kor. Acupuncture Moxibustion Soc. 20, 63-74, 2003.
  23. Choi, Y.H., Kong, K.R., Kim, Y.A., Jung, K.O., Kil, J.H., Rhee, S.H., Park, K.Y., Induction of Bax and activation of caspases during $\beta$-sitosterol-mediated apoptosis in human colon cancer cells. Int. J. Oncol. 23, 1657-1661, 2003.
  24. Hockenbery, D.M., Oltvai, Z.N., Yin, X.M., Milliman, C.L., Korsmeyer, S.J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251, 1993.
  25. Lowe, S.W., Ruley, H.E., Jacks, T., Housman, D.E., p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-967, 1993.
  26. Rosse, T., Olivier, R., Monney, L., Rager, M., Conus, S., Fellay, L., Jansen, B. and Borner, C., Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391, 496-499, 1998.
  27. Miyashita, T., Reed, J.C., Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299, 1995.
  28. Harper, J.W., Adami, C.R., Wei, N., Keyomarsi, K., Elledge, S.J., The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816, 1993.
  29. El-Deiry, W.S., Tokino, T., Velculesco, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, E.W., Kinzler, K.W., Vogelstain, B., WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825, 1993.
  30. Kyo, S. and Inoue, M., Complex regulatory mechanisms of telomerase activity in normal and cancer cells: How can we apply them for cancer therapy. Oncogene 21, 688-697, 2002.
  31. Poole, J.C., Andrews, L.G. and Tollefsbol, T.O., Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 269, 1-12, 2001.
  32. Cerni, C., Telomeres, telomerase, and myc. An update. Mutat. Res. 462, 31-47, 2000.